Mi Ra Chang

1.3k total citations
29 papers, 993 citations indexed

About

Mi Ra Chang is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Mi Ra Chang has authored 29 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Physiology. Recurrent topics in Mi Ra Chang's work include Peroxisome Proliferator-Activated Receptors (7 papers), Estrogen and related hormone effects (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Mi Ra Chang is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Estrogen and related hormone effects (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Mi Ra Chang collaborates with scholars based in United States, Australia and South Korea. Mi Ra Chang's co-authors include Patrick R. Griffin, Theodore M. Kamenecka, Brent Lyda, Dana S. Kuruvilla, Scott J. Novick, Thomas P. Burris, Cesar A. Corzo, Bruce D. Pascal, Rubén D. Garcia-Ordoñez and Naresh Kumar and has published in prestigious journals such as Cell, Nature Communications and PLoS ONE.

In The Last Decade

Mi Ra Chang

28 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Ra Chang United States 17 465 257 254 151 132 29 993
Rubén D. Garcia-Ordoñez United States 16 580 1.2× 256 1.0× 146 0.6× 169 1.1× 222 1.7× 25 1.2k
Peter Christmas United States 17 657 1.4× 235 0.9× 232 0.9× 114 0.8× 83 0.6× 19 1.3k
Benoît Boivin United States 14 1.0k 2.2× 218 0.8× 371 1.5× 83 0.5× 47 0.4× 26 1.5k
Nicolas Coant United States 20 785 1.7× 187 0.7× 214 0.8× 116 0.8× 44 0.3× 30 1.2k
Kristine Griffett United States 15 417 0.9× 93 0.4× 122 0.5× 166 1.1× 90 0.7× 25 926
G. Cricco Argentina 21 814 1.8× 615 2.4× 138 0.5× 211 1.4× 91 0.7× 53 1.3k
Hee Sun Byun South Korea 20 757 1.6× 155 0.6× 162 0.6× 114 0.8× 64 0.5× 38 1.2k
Yong Kyung Kim South Korea 16 426 0.9× 152 0.6× 296 1.2× 105 0.7× 35 0.3× 17 929
Mounib Elchebly Canada 17 643 1.4× 164 0.6× 251 1.0× 88 0.6× 69 0.5× 24 1.2k
Dara E. Leto United States 12 931 2.0× 100 0.4× 354 1.4× 78 0.5× 86 0.7× 13 1.4k

Countries citing papers authored by Mi Ra Chang

Since Specialization
Citations

This map shows the geographic impact of Mi Ra Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Ra Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Ra Chang more than expected).

Fields of papers citing papers by Mi Ra Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Ra Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Ra Chang. The network helps show where Mi Ra Chang may publish in the future.

Co-authorship network of co-authors of Mi Ra Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Ra Chang. A scholar is included among the top collaborators of Mi Ra Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Ra Chang. Mi Ra Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frkic, Rebecca L., Blagojce Jovcevski‬, Wioleta Kowalczyk, et al.. (2023). PPARγ Corepression Involves Alternate Ligand Conformation and Inflation of H12 Ensembles. ACS Chemical Biology. 18(5). 1115–1123. 5 indexed citations
2.
Czernik, Piotr J., et al.. (2023). Osteocytes contribute via nuclear receptor PPAR-alpha to maintenance of bone and systemic energy metabolism. Frontiers in Endocrinology. 14. 1145467–1145467. 12 indexed citations
3.
Chang, Mi Ra & Patrick R. Griffin. (2022). RORβ modulates a gene program that is protective against articular cartilage damage. PLoS ONE. 17(10). e0268663–e0268663. 5 indexed citations
4.
Strutzenberg, Timothy S., Scott J. Novick, Rubén D. Garcia-Ordoñez, et al.. (2021). Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement. Journal of Molecular Biology. 433(22). 167258–167258. 3 indexed citations
5.
Chang, Mi Ra, Timothy S. Strutzenberg, Scott J. Novick, et al.. (2019). Unique Polypharmacology Nuclear Receptor Modulator Blocks Inflammatory Signaling Pathways. ACS Chemical Biology. 14(5). 1051–1062. 8 indexed citations
6.
Strutzenberg, Timothy S., Rubén D. Garcia-Ordoñez, Scott J. Novick, et al.. (2019). HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists. eLife. 8. 12 indexed citations
7.
Zheng, Jie, Chen Wang, Mi Ra Chang, et al.. (2018). HDX-MS reveals dysregulated checkpoints that compromise discrimination against self RNA during RIG-I mediated autoimmunity. Nature Communications. 9(1). 5366–5366. 30 indexed citations
8.
Zheng, Jie, Cesar A. Corzo, Mi Ra Chang, et al.. (2018). Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism. Structure. 26(11). 1431–1439.e6. 24 indexed citations
9.
Doebelin, Christelle, Rubén D. Garcia-Ordoñez, Mi Ra Chang, et al.. (2018). Identification of potent RORβ modulators: Scaffold variation. Bioorganic & Medicinal Chemistry Letters. 28(19). 3210–3215. 2 indexed citations
10.
Zheng, Jie, Mi Ra Chang, Yong Wang, et al.. (2017). HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions. Nature Communications. 8(1). 923–923. 35 indexed citations
11.
Frkic, Rebecca L., Yuanjun He, Mi Ra Chang, et al.. (2017). Structure–Activity Relationship of 2,4-Dichloro- N -(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted Antidiabetics. Journal of Medicinal Chemistry. 60(11). 4584–4593. 23 indexed citations
12.
Long, Jonathan Z., Katrin J. Svensson, Leslie A. Bateman, et al.. (2016). The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria. Cell. 166(2). 424–435. 191 indexed citations
13.
Doebelin, Christelle, Rubén D. Garcia-Ordoñez, Mi Ra Chang, et al.. (2016). N‐Arylsulfonyl Indolines as Retinoic Acid Receptor‐Related Orphan Receptor γ (RORγ) Agonists. ChemMedChem. 11(23). 2607–2620. 19 indexed citations
14.
Chang, Mi Ra, Yuanjun He, Tanya Khan, et al.. (2015). Antiobesity Effect of a Small Molecule Repressor of RORγ. Molecular Pharmacology. 88(1). 48–56. 33 indexed citations
15.
Chang, Mi Ra, et al.. (2015). Personal Backgrounds and Differences in Urban Older Adults’ Leisure Time Use. British Journal of Education Society & Behavioural Science. 9(4). 300–317. 1 indexed citations
16.
Marciano, David, Mi Ra Chang, Cesar A. Corzo, et al.. (2014). The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs. Cell Metabolism. 19(2). 193–208. 98 indexed citations
17.
Corzo, Cesar A., Mi Ra Chang, Tanya Khan, et al.. (2014). Antiproliferation Activity of a Small Molecule Repressor of Liver Receptor Homolog 1. Molecular Pharmacology. 87(2). 296–304. 31 indexed citations
18.
Chang, Mi Ra, Hugh Rosen, & Patrick R. Griffin. (2014). RORs in Autoimmune Disease. Current topics in microbiology and immunology. 378. 171–182. 16 indexed citations
19.
Hughes, Tudor, Michael J. Chalmers, Scott J. Novick, et al.. (2012). Ligand and Receptor Dynamics Contribute to the Mechanism of Graded PPARγ Agonism. Structure. 20(1). 139–150. 122 indexed citations
20.
Griffin, Patrick, et al.. (2012). The therapeutic potential of RORγ modulators in the treatment of human disease. Journal of Experimental Pharmacology. 4. 141–141. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026